To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Wearable TENS for Enhancing Exercise Therapy in Chronic Knee Pain

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2025

Wearable TENS for Enhancing Exercise Therapy in Chronic Knee Pain

Vol: 307| Issue: 6| Number:73| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Usefulness and Safety of a Wearable Transcutaneous Electrical Nerve Stimulation Device for Promoting Exercise Therapy in Patients With Chronic Knee Pain: A Randomized Controlled Trial.

Arch Phys Med Rehabil. 2025 Feb;106(2):167-176.

Contributing Authors:
K Yamada H Shimizu N Doi K Harada M Ishizuka-Inoue R Yamashita S Takamatsu S Hayashi-Nishiyama Y Okamoto T Aoyama

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Sixty-three patients with chronic knee pain (aged ≥50 years) were randomized to receive either TENS therapy (n=21), exercise therapy (n=23), or both TENS and exercise therapy (n=19) over 4 weeks. The primary outcome was physical activity (PA), measured objectively via activity monitors. Secondary outcomes included the 6-minute walk test (6MWT), Timed Up and Go (TUG) test, stair climbing, pain duri...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue